FOXO3 and prostate cancer: Our unpublished data demonstrates that SIRT1 down-regulation in prostate cancer cell lines increases the levels of FOXO3a protein, suggesting a role for deacetylation by SIRT1 in ubiquitin-mediated FOXO3a protein degradation.